PEGYLATED LIPOSOMES FOR DELIVERY OF RNA ENCODING AN IMMUNOGEN
CY1126013T1Undetermined Publication Date: 2026-07-31GLAXOSMITHKLINE BIOLOGICALS SA
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100097T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2010-08-31
- Filing Date
- 2023-02-21
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2043-02-21
Abstract
Nucleic acid immunization is achieved by administering RNA encapsulated within a pegylated liposome. The RNA encodes an immunogen of interest. The PEG has an average molecular mass of between 1 kDa and 3 kDa. Accordingly, the invention provides a liposome having a lipid bilayer encapsulating an aqueous core, wherein: (i) the lipid bilayer comprises at least one lipid containing a polyethylene glycol moiety, such that the polyethylene glycol is on the exterior of the liposome, wherein the average molecular mass of the polyethylene glycol is between 1 kDa and 3 kDa' and (ii) the aqueous core contains an RNA encoding an immunogen. These liposomes are suitable for in vivo delivery of RNA to a vertebrate cell and are therefore useful as components of pharmaceutical compositions for immunizing individuals against various diseases.
Need to check novelty before this filing date? Find Prior Art